![Andre Aarøen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Profiel
Andre Aarøen is currently the Chairman of Flåmsbrygga Hotell AS and Defibrio AS.
Actieve functies van Andre Aarøen
Bedrijven | Functie | Begin |
---|---|---|
Flåmsbrygga Hotell AS
![]() Flåmsbrygga Hotell AS Hotels/Resorts/Cruise linesConsumer Services Flåmsbrygga Hotell AS is a private company based in Flåm, Norway. Flåmsbrygga Hotell AS operates hotels, boarding houses, and motels. The Norwegian company was founded in 2014 and is led by CEO Aud Melås. | Voorzitter | - |
Defibrio AS
![]() Defibrio AS Medical SpecialtiesHealth Technology Defibrio AS is a Norwegian company that focuses on saving lives by providing immediate access to automatic external defibrillators (AEDs). The company is based in Fana, Norway and was founded in 2020. The company's mission is to increase the survival rate of sudden cardiac arrest (SCA), which currently has a low survival rate of 10%%. SCA kills millions of people worldwide every year, with 70%% of deaths occurring in the home. Defibrio aims to reduce the chance of death by providing quick access to AEDs. The CEO is Arne Gjerde Bergby. | Voorzitter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Bedrijven in privébezit | 2 |
---|---|
Flåmsbrygga Hotell AS
![]() Flåmsbrygga Hotell AS Hotels/Resorts/Cruise linesConsumer Services Flåmsbrygga Hotell AS is a private company based in Flåm, Norway. Flåmsbrygga Hotell AS operates hotels, boarding houses, and motels. The Norwegian company was founded in 2014 and is led by CEO Aud Melås. | Consumer Services |
Defibrio AS
![]() Defibrio AS Medical SpecialtiesHealth Technology Defibrio AS is a Norwegian company that focuses on saving lives by providing immediate access to automatic external defibrillators (AEDs). The company is based in Fana, Norway and was founded in 2020. The company's mission is to increase the survival rate of sudden cardiac arrest (SCA), which currently has a low survival rate of 10%%. SCA kills millions of people worldwide every year, with 70%% of deaths occurring in the home. Defibrio aims to reduce the chance of death by providing quick access to AEDs. The CEO is Arne Gjerde Bergby. | Health Technology |